Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a cancer and leukemia group B study

The response to cisplatin in non-small cell lung cancer (NSCLC) is limited by the renal and neurological toxicities of this agent. Carboplatin has modest activity in NSCLC and when given in conventional doses has a different spectrum of toxicity. Both drugs were administered to 76 eligible patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer & clinical oncology 1990, Vol.26 (10), p.1057-1060
Hauptverfasser:	Kreisman, Harvey, Goutsou, Maria, Modeas, Caron, Graziano, Stephen L., Costanza, Mary E., Green, Mark R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antineoplastic Combined Chemotherapy Protocols - toxicity Biological and medical sciences Carboplatin - administration & dosage Carboplatin - toxicity Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - mortality Cisplatin - administration & dosage Cisplatin - toxicity Drug Evaluation Female Humans Lung Neoplasms - drug therapy Lung Neoplasms - mortality Male Medical sciences Middle Aged Pneumology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!